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An important property of dendritic cells (DC), which
contributes crucially to their strong immunogenic func-
tion, is their capacity to migrate from sites of antigen
capture to the draining lymphoid organs. Here we studied
in detail the migratory pathway and the differentiation
of DC during migration in a skin organ culture model
and, for comparison, in the conventional contact hyper-
sensitivity system. We report several observations on the
capacity of cutaneous DC to migrate in mouse ear skin.
(i) Upon application of contact allergens in vivo the
density of Langerhans cells in epidermal sheets decreased,
as determined by immunostaining for major histocom-
patibility complex class II, ADPase, F4/80, CD11b, CD32,
NLDC-145/DEC-205, and the cytoskeleton protein
vimentin. Evaluation was performed by computer
assisted morphometry. (ii) Chemically related nonsensit-
izing or tolerizing compounds left the density of Langer-
hans cells unchanged. (iii) Immunohistochemical double-
Tcell responsiveness requires the involvement of accessorycells that fulfil three broad functions. First, they have tobe able to capture antigens and generate immunogenicmajor histocompatibility complex (MHC)/peptide com-plexes. Second, they have to migrate from the sites of
antigen capture to draining lymphoid organs in order to find antigen
specific T lymphocytes. Third, they must be efficient in presenting
the MHC/peptide complexes to the T cells together with the necessary
adhesion molecules and costimulatory signals. Dendritic cells (DC) are
highly specialized to perform this task (Steinman, 1991; Schuler
et al, 1997).
A precondition for the generation of primary immune responses is
that antigens be brought into lymphoid organs by blood, lymph, or
mobile antigen-presenting cells (Zinkernagel, 1996). It follows that
motility and mobility must be key properties of DC. It is essential that
they be able to carry immunogenic MHC/peptide complexes from
the places of antigen capture, which are often tissues bordering to the
outside world, to those locales where a primary immune response takes
place, i.e., the draining lymphoid organs. Classical experiments by
Austyn et al have established that DC can migrate and home to the T
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staining of dermal sheets from skin organ cultures for
major histocompatibility complex class II and CD54
excluded blood vessels as a cutaneous pathway of DC
migration. (iv) Electron microscopy of organ cultures
revealed dermal accumulations of DC (including Birbeck
granule containing Langerhans cells) within typical
lymphatic vessels. (v) Populations of migrating DC in
organ cultures upregulated markers of maturity (the
antigen recognized by monoclonal antibody 2A1, CD86),
but retained indicators of immaturity (invariant chain,
residual antigen processing function). These data provide
additional evidence that during both the induction of
contact hypersensitivity and in skin organ culture,
Langerhans cells physically leave the epidermis. Both
Langerhans cells and dermal DC enter lymphatic vessels.
DC mature while they migrate through the skin. Key
words: contact hypersensitivity/Langerhans cells/migration/
organ culture. J Invest Dermatol 110:441–448, 1998
areas of lymphoid organs (reviewed in Austyn, 1989, 1996). Evidence
for migration of DC upon antigenic challenge comes mainly from
studies in the murine contact hypersensitivity model. Upon epicutane-
ous application of contact sensitizers, the numbers of immunohisto-
chemically detectable MHC class II expressing cells in the epidermis
(i.e., Langerhans cells) decreases (Bergstresser et al, 1980; Botham et al,
1987; Steinbrink et al, 1996), occasional veiled cells (i.e., DC) can be
found in lymphatic vessels (Silberberg-Sinakin et al, 1976; Schuler et al,
1991), and hapten-loaded, functional DC can be detected in and
isolated from the draining lymph nodes (Macatonia et al, 1987). Larsen
et al (1990) established a murine organ culture model where they could
directly show migration of epidermal Langerhans cells from the
epidermis through the dermis into the culture medium. They noted
that strongly MHC class II expressing cells, i.e., DC, accumulated in
the dermis in a characteristic string-like pattern that they termed
‘‘cords.’’ Dermal ‘‘cords’’ were eventually also found in vivo in mice
injected with lipopolysaccharide (Roake et al, 1995). In human skin
organ cultures we could show that ‘‘cords’’ are lymphatic vessels (Lukas
et al, 1996). For the murine skin culture model this has not yet been
shown. Moreover, the relative contributions of epidermal Langerhans
cells and dermal DC to the ‘‘cord’’ populations are unclear. Therefore,
we attempted to study in more detail the pathway of DC migration
in murine skin organ cultures. Moreover, we extended earlier investi-
gations on the issue of Langerhans cell emigration from the epidermis
in response to haptens in vivo. We used antibodies to the cytoskeletal
protein vimentin and electron microscopy as a means to monitor
immunohistochemically and ultrastructurally the disappearance of
Langerhans cells from the epidermis.
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MATERIALS AND METHODS
Mice and media Mice of inbred strains C57BL/6, BALB/C, and C3H/He
were purchased from Charles River (Sulzfeld, Germany) and used at 6–12 wk
of age. Each control or experimental panel consisted of three to five mice. The
culture medium used throughout was RPMI 1640 supplemented with 10%
fetal calf serum, gentamycin (all from Biological Industries, Kibbutz Beit
Haemek, Israel), and 2-mercaptoethanol (Sigma, St. Louis, MO).
Induction of contact sensitivity The contact sensitizers 2,4-dinitro-1-
chloro-benzene (DNCB) and 2,4-dinitro-1-fluorobenzene (DNFB) were
obtained from Sigma, and 2,4,6-trinitro-1-chlorobenzene (picryl-chloride,
TNCB) was from Kodak Eastman (Rochester, NY). The tolerogen 2,4-
dinitrothiocyanatebenzene (DNTB) was purchased from ICN Biochemicals
(Plainview, NY), and the nonsensitizer 2,4-dichloro-1-nitrobenzene (DCNB)
was from Aldrich (Gillingham, U.K.) (Botham et al, 1987). All substances were
applied onto the left ears of nonsensitized animals (10 µl per dorsal ear-half) at
the subtoxic concentration of 1% in acetone-olive oil (4:1). A toxic effect was
excluded by histologic examination of paraffin sections. The sensitizing potency
was verified by elicitation experiments.
Elicitation of contact sensitivity Five days after sensitization, the right
dorsal ear-halves were challenged with 5 µl of 1% hapten in acetone-olive oil.
Twenty-four and 48 h after antigen challenge ear thickness was measured and
compared with that of unsensitized control animals that had received only the
challenge dose (Phanuphak et al, 1974). Ear thickness was quantitated using an
engineer’s micrometer (Peacock, Ozaki, Japan).
Skin organ culture Dorsal (i.e., cartilage-free) ear halves were rinsed in 70%
ethanol, air-dried for µ10 min, and cultured in 24 well tissue culture plates
(Costar, Cambridge, MA) in 1.5 ml of culture medium at 37°C (Larsen et al,
1990; Ortner et al, 1996; Romani et al, 1997). One ear-half was placed into
one well. Cultures were fed after 2 d by carefully aspirating 800 µl of spent
medium and adding back the same volume of fresh medium. In some
experiments skin was separated into epidermis and dermis by means of protease
dispase before the onset of culture, using a previously described method (Kitano
and Okado, 1983; Lenz et al, 1993).
Immunohistochemical techniques The epidermis was separated from the
dermis by means of ammoniumthiocyanate as previously described (Juhlin and
Shelley, 1977). Acetone-fixed (5 min at room temperature) epidermal and
dermal sheets were immunostained applying the following sequence of steps:
primary rat or mouse monoclonal antibodies (MoAb) (24 h at 14°C), biotinyl-
ated anti-rat or mouse Ig (Amersham International, Amersham, U.K.; 90 min
at 37°C), streptavidin-peroxidase complex or streptavidin Texas Red (both
from Amersham; 90 min at 37°C). Alternatively, rat MoAb were visualized by
a previously described sensitive three-step method (Romani et al, 1985) using
a mouse polyclonal anti-rat Ig (a kind gift of Dr. R. North, Trudeau
Institute, Saranac Lake, NY) followed by tetramethylrhodamine isothiocyanate-
conjugated goat F(ab9)2 anti-mouse IgG 1 IgM (90 min at 37°C, Tago,
Burlingame, CA). The immunoperoxidase protocol was continued by visualizing
peroxidase acitivity with 3939-diaminobenzidine-H2O2. Immunofluorescence
was carried on by double-labeling for MHC class II in order to identify DC.
After a blocking step with rat Ig (100 µg per ml), sheets were incubated in a
final step with fluorescein isothiocyanate-conjugated anti-MHC class II [clone
2G9; Pharmingen (San Diego, CA) or MoAb B21–2/anti-I-Ab,d conjugated
with fluorescein according to standard methods; 4°C/overnight]. Fluorescent
sheets were mounted onto microscopic slides in Vectashield (Vector, Burlingame,
CA) mounting medium. To visualize vimentin intermediate filaments it was
advantageous to add 0.5% saponin (Sigma) to all washing solutions and antibody
dilutions. This treatment enhanced antibody penetration into the cytoplasm of
the cells. It did not change the staining pattern of the other antibodies used in
this study.
Antibodies Anti-I-Ab,d (B21–2/TIB229; rat IgG2b; R.M. Steinman, The
Rockefeller University, New York, NY); anti-I-Ad (MK-D6/HB3; mouse
IgG2a; ATCC, Rockville, MD); anti-I-Ak,r,f,s (10–2.16/TIB93; mouse IgG2b;
R.M. Steinman); anti-I-Ek,d (14–4–4S/HB32; mouse IgG2a; ATCC); invariant
chain (In1; rat IgG2b, N. Koch, University of Bonn, Germany); anti-macrophage
(F4/80/HB198; rat IgG2b; ATCC); anti-CD11b/Mac-1 (M1/70/TIB128;
rat IgG2b; ATCC); anti-CD32/FcγRII (2.4G2/HB197; rat IgG2b; ATCC);
dendritic cells/DEC-205 (NLDC145; rat IgG2a; G. Kraal, Free University,
Amsterdam, The Netherlands; Kraal et al, 1986); intracytoplasmic, vesicle-
bound molecule (2A1; rat IgG2a; R.M. Steinman; positive in mature DC/
negative in immature DC; Inaba et al, 1992); CD54/ICAM-1 (BE29G1; rat
IgG2a; B.A. Lollo, University of California, San Diego; Kuhlman et al, 1991);
CD86/B7–2 (GL1; rat IgG2a; Pharmingen, San Diego, CA; positive in mature
DC/negative in immature DC; Inaba et al, 1994); anti-vimentin (mouse IgM;
Figure 1. The density of Langerhans cells decreases specifically in
response to contact allergens. One per cent solutions of different sensitizing
or nonsensitizing compounds were applied epicutaneously. Epidermal sheets
of BALB/C mice were evaluated by counting under the microscope. (A)
Immunohistochemistry using MoAb against I-A (MoAb B21–2) and I-E (MoAb
HB-32) as well as enzyme-histochemistry (ADPase) show a similar decrease in
Langerhans cell densities in the first 2 d after application of TNCB. (B)
Immunostaining for MHC class II (MoAb B21–2) reveals a decrease of
Langerhans cells in response to three different contact sensitizers (DNFB,
DNCB, TNCB). In contrast, a nonsensitizing (DCNB) and a tolerizing (DNTB)
compound left the Langerhans cell numbers unchanged. Error bars, mean 6 SD
(n 5 5).
V. Small, Austrian Academy of Sciences, Salzburg, Austria, and P. Leoncini,
Istituto Sclavo, Siena, Italy; Cintorino et al, 1989); and anti-vimentin (polyclonal
rabbit Ig; F. Ramaekers, University of Nijmegen, The Netherlands; de Waal
et al, 1984).
ADPase-staining Epidermal sheets were prepared as described above, fixed
in 5% paraformaldehyde in 0.1 M sodium cacodylate buffer, and stained for
nucleoside-diphosphatase according to the method of Chaker et al (1984).
Evaluation of immunohistochemistry The density of Langerhans cells in
epidermal sheets was counted under the microscope using 340 objective lenses
and a calibrated grid. Areas to be counted were selected for interfollicular
regions of even staining and regular distribution of positive cells. There, 50
grids were randomly chosen for each antibody and experiment (150 for
controls). Fields containing hair follicles were excluded from analyses. Mean
values and standard deviations were determined. In addition, epidermal sheets
stained with the peroxidase technique were subjected to image analysis using
bright field microscopy (Axiomat; Zeiss, Oberkochen, Germany). At a magni-
fication of 3250, at least 200 randomly selected visual fields were evaluated for
each experimental condition in a fully automated system (VIDAS; Kontron,
Mu¨nchen, Germany). Langerhans cells were counted and basic statistical
parameters (mean, standard deviation, Mann–Whitney U test: p , 0.01) were
calculated.
Electron microscopy Skin organ cultures were fixed with Karnovsky’s half
strength formaldehyde-glutaraldehyde reagent and further processed as described
(Sto¨ssel et al, 1990). Ultra-thin sections were evaluated on a Philips EM 400
(Philips, Eindhoven, The Netherlands) electron microscope.
Functional assays Antigen processing capacity of DC was measured by means
of a hen egg lysozyme peptide specific TT hybridoma [Hd-1.AC5 (Jensen,
1988); a kind gift of Dr. S.I. Katz, Bethesda, MD] as described (Koch et al,
1995). The capacity to sensitize resting T cells was determined in a oxidative
mitogenensis assay (Schuler and Steinman, 1985).
RESULTS
Langerhans cells leave the epidermis both after epicutaneous
application of contact sensitizers and upon skin organ culture
immunohistochemistry Using TNCB as contact sensitizer and
anti-MHC class II MoAb, as well as ADPase reactivity, to visualize
Langerhans cells, a progressive reduction in the number of reactive
cells, i.e., Langerhans cells, was observed (Fig 1). One hour after
application an insignificant decrease of 10–20% was evident. The
number of reactive cells dropped in a time dependent fashion and
reached the lowest levels at 48 h; 30–40% reduction as compared with
the untreated control (Fig 1). Langerhans cell densities then slowly
recovered but still remained about 20% below control levels at 96 h.
It was consistently noted that the numerical reduction was more
pronounced with ADPase as a Langerhans cell marker than with anti-
MHC class II MoAb (Fig 1A). The morphologic appearance of this
reduction was a general thinning out of antibody/enzyme reactive
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Table I. The density of Langerhans cells decreases specifically in response to contact allergensa
Treatment 0 h 1 h 24 h 48 h
Anti-MHC class II immunostaining
None 1219 6 189 (100%)
Acetone/olive oil 996 6 196 (–18%) 1070 6 214 (–12%) 1073 6 237 (–12%)
TNCB 994 6 222 (–18%) 759 6 200 (–38%) 687 6 209 (–44%)
DNTB nt 1037 6 196 (–15%) 1074 6 209 (–12%)
DCNB nt 1091 6 218 (–11%) 1073 6 216 (–12%)
Anti-vimentin immunostaining
None 1211 6 195 (100%)
Acetone/olive oil nt nt 1080 6 165 (–11%)
TNCB nt nt 783 6 153 (–36%)
DCNB nt nt 1054 6 198 (–13%)
aEpidermal sheets from ears of BALB/C mice that had been treated epicutaneously with the indicated reagents (see Material and Methods) were immunostained for MHC class II (MoAb
B21–2) or vimentin and evaluated by morphometry. Langerhans cell densities at 24 and 48 h after TNCB (i.e., sensitizer) treatment were significantly decreased (underlined; p ø 0.01;
Mann–Whitney U test) as compared with both untreated epidermis (100%) and acetone-olive oil, or nonsensitizer treated (i.e., DNTB and DCNB) epidermis. One hour values were
not significantly different. One experiment of two is shown here. Numbers indicate Langerhans cells per mm2 6 SD. Ac/ol-oil, acetone/olive oil; nt, not tested.
cells. Patches totally devoid of staining were occasionally observed.
Langerhans cells in hapten treated epidermal sheets were bigger than
on untreated sheets or acetone-olive oil treated sheets, and their class
II expression was clearly enhanced (not shown). They did not look
damaged, though. Cell counts were confirmed by computer assisted
morphometrical analysis (Table I). An identical time dependent reduc-
tion of Langerhans cells as determined by anti-MHC class II immunola-
beling was found for the other contact allergens, DNCB and DNFB
(Fig 1B). The application of acetone-olive oil alone resulted in a
consistent reduction by about 12% in the number of cells reacting
with anti-MHC class II MoAb (Table I) and displaying ADPase
reactivity. In epidermal sheets from cultured ear-halves we noted a
much more pronounced decrease in the density of class II positive
epidermal cells, i.e., Langerhans cells (data not shown). The values for
days 1 and 3 of culture were 50% and 75%, respectively, lower than
those of untreated epidermis. This was exactly as described by Larsen
et al (1990).
To ascertain whether the observed reduction in the numbers of
antibody-reactive cells was due to the physical disappearance of the
cells from the epidermis rather than to a mere loss of surface antigens,
we stained epidermal sheets from TNCB treated mice with different
anti-vimentin reagents. These experiments were carried out with
BALB/C mice that contain only negligible numbers of vimentin
expressing dendritic, γ/δ TCR bearing epidermal T cells (Bergstresser
et al, 1983; Tschachler et al, 1983). Again, a concomitant reduction of
vimentin and MHC class II reactive cells was observed. Forty-eight
hours after application of TNCB, morphometrical analysis revealed a
statistically significant difference (p ø 0.01) between vimentin-positive
cells in sheets from control skin versus sensitizer treated skin (Table I).
Reduction of vimentin-positive cells was 36% and 28% in relation to
untreated and vehicle treated epidermis, respectively (Table I; Fig 2).
Likewise, in organ cultures the density of vimentin reactive cells
dropped concomitantly with the numbers on MHC class II reactive
cells (Fig 2).
When epidermal sheets of TNCB treated mice were stained with
MoAb against other antigens expressed on the surface of resident
Langerhans cells (F4/80, CD11b, CD32, NLDC-145/DEC-205), an
identical pattern of reduction was found. Moreover, double-labeling
for these antigens and MHC class II demonstrated that all cells positive
for CD11b, CD32, F/80 macrophage antigen, and NLDC were also
positive for MHC class II and vice versa. In other words, there
appeared to be no cells that had lost class II but still expressed one of
the other antigens and vice versa.
For all three contact allergens we obtained ear swelling responses
that were comparable with the published values (Phanuphak et al,
1974; Bergstresser et al, 1980; Cruz et al 1989) (data not shown).
Numbers of Langerhans cells do not decrease after epicutaneous
application of a tolerizing or a nonsensitizing substance It has
been shown that chemically closely related compounds exert different
effects when applied epicutaneousely. Whereas DNCB is a contact
Figure 2. Vimentin reactive epidermal DC (i.e., Langerhans cells)
decrease in response to contact allergens and in organ culture.
Distribution of vimentin-reactive cells in epidermal sheets from untreated (left
panels) versus TNCB treated (48 h; upper right) and cultured (48 h; lower right)
skin. Evaluation by counting and morphometry showed that the reduction of
Langerhans cells amounted to 36% after TNCB and .80% after culture. Note
the larger size and the distorted morphology of Langerhans cells in contact
allergen treated and cultured skin (right panels). Scale bar, 50 µm.
sensitizer, DCNB does not sensitize mice (Botham et al, 1987; Kolde
and Knop, 1987). Similarly, DNTB that is structurally similar to the
sensitizer DNFB induces specific tolerance (Kolde and Knop, 1987),
at least at the concentration used in this study (Dearman et al, 1997).
We therefore wondered whether these differential sensitizing potentials
were reflected by a differential migratory behavior of Langerhans cells.
Using anti-MHC class II (anti-I-A and anti-I-E) as well as anti-
vimentin MoAb, we observed the expected numerical decrease of
antibody-reactive cells in response to the known contact sensitizers
(Fig 1). In contrast, skin painting with DNTB (1%) and the nonsensit-
izer DCNB (1%) left the Langerhans cell densities virtually unchanged.
After 48 h the decrease in the number of labeled cells was not more
than the decrease recorded in the acetone-olive oil control (Fig 1B).
Staining with anti-vimentin antibodies yielded identical results. The
size and shape of Langerhans cells as well as anti-class II staining
intensity on tolerogen and nonsensitizer treated epidermal sheets did
not differ from control sheets. Evaluation by computer assisted image
analysis confirmed the data (Table I).
DC enter lymphatic vessels in skin organ culture and, to a lesser
degree, after epicutaneous application of contact sensitizers
Like Larsen et al (1990), we observed abundant accumulations of
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Figure 3. Migratory DC do not accumul-
ate in dermal blood vessels. Dermal ‘‘cords,’’
visualized by immunohistochemistry for MHC
class II, form in untreated skin cultured for 3 d
(A, C, D) and 3 d after in vivo application of
a contact sensitizer (TNCB) (B). Note the
characteristic nonrandom, string-like distribu-
tion of strongly MHC class II expressing cells.
In (C) and (D) dermal sheets were double-
labeled with MoAb against CD54/ICAM-1,
identifying blood endothelia (red fluorescence) and
class II, identifying DC (green fluorescence). There
is no overlap between the two markers,
suggesting that the ‘‘cords’’ (green fluorescence) do
not represent blood vessels. Scale bars, (A, B)
75 µm; (C, D) 50 µm.
Figure 4. Morphology of migratory DC on semi-thin sections of
cultured skin. Skin was cultured for 3 d and embedded for electron microscopy.
Methylene blue stained 1 µm sections show cells with the typical morphology
of DC (lobulated and excentric nuclei, light cytoplasm). They are located in
wide clefts in the dermis, marked with triangles. Of the thin endothelial cell
lining only the characteristic nuclei (arrows) that bulge into the lumen can be
appreciated. (B) is a higher mignification of (A). Scale bars, (A) 50 µm, (B) 25 µm.
strongly class II cells in dermal sheets (‘‘cords’’) after 2–3 d of culture
(Fig 3A). ‘‘Cords’’ also developed in vivo in contact sensitizer treated
(TNCB) skin (Fig 3B), though their frequency was markedly lower
than in organ culture. In addition, we harvested typical mature DC
from the culture medium as described (Larsen et al, 1990; Ortner et al,
1996). When the epidermis was removed from the dermis by dispase
treatment and the dermal part was cultured by itself for 2–3 d, the
same structures could be found. This shows that dermal DC also
migrate via lymph vessels (see below).
Double-labeling of dermal sheets from skin cultured for 2–3 d for
MHC class II (identifying DC and thus ‘‘cords’’) and CD54/ICAM-1
(identifying blood vessel endothelia; Kuhlman et al, 1991), revealed
that the ‘‘cords’’ were CD54 negative. Conversely, CD54-positive
structures with the typical morphology of blood vessels did not contain
DC (Fig 3C, D). These findings rule out the possibility that dermal
‘‘cords’’ might be blood vessels.
On semi-thin sections of cultured skin specimens embedded for
electron microscopy, accumulations of DC in the dermis became
readily apparent. Figure 4 shows considerable numbers of conspicuous
cells in wide clefts that correspond to the immunohistochemically
detectable ‘‘cords.’’ The cells exhibit features typical for DC, such as
long and thin cytoplasmic processes (‘‘veils’’), lobulated and excentrically
localized nuclei, and a light cytoplasm. They are surrounded by a very
thin endothelial lining of which, on semi-thin sections, only the
characteristic nuclei that protrude into the lumen can be seen.
Electron microscopy provided the ultrastructural proof that the
‘‘cords’’ in cultured murine skin were in fact lymphatic vessels. The
dermal clefts were lined by a thin sheet of endothelial cytoplasm. These
endothelial cells rested on a discontinuous, in most places absent,
basement membrane (Fig 5). Anchoring filaments extending from the
ablumenal plasma membrane into the underlying connective tissue
were observed (Gerli et al, 1991). Weibel-Palade bodies, which are
characteristic for blood endothelial cells (Ryan, 1989), were not
detected. Occasionally the endothelial lining was interrupted. Tight
junctional specializations as seen in blood endothelia did not occur.
Pericytes were not present; erythrocytes were not found. The cells
within the lumena of the vessels displayed all signs of mature DC.
They extended thin and long cytoplasmic, organelle-free sheets (‘‘veils’’)
in all directions. The nuclei were strongly lobulated. The electron-
light cytoplasm contained few typical electron-dense lysosomes but
many small, peripherally located electron-lucent (‘‘empty’’) vesicles and
a variable number of multivesicular organelles that, by mere morpho-
logy, corresponded to MHC class II containing organelles or ‘‘MIIC’’
(Kleijmeer et al, 1994). In profiles of 25 different DC an average of
four (range 0–12) such organelles were found (Fig 5). Furthermore,
DC displayed typical profiles of smooth endoplasmic reticulum. Birbeck
granules were found in about one-fourth of DC; however, as compared
with resident epidermal Langerhans cells their numbers were much
less and they looked small and stunted.
Maturation of DC during migration We attempted to define the
maturational state of migrating DC in organ cultures by immunohisto-
chemistry for molecules that are differentially expressed on/in immature
and mature DC (Table II), i.e., MoAb 2A1 and MoAb GL1 (anti-
CD86) as markers for maturity; MoAb In1 (invariant chain) as an
indicator for immaturity. In untreated epidermis, Langerhans cells in
situ express MHC class II (mostly intracellularly; Kleijmeer et al, 1994;
Mommaas et al, 1995) and invariant chain, but no CD86 nor the
antigen recognized by MoAb 2A1. MHC class II expression in organ
cultures is upregulated within a few hours (Larsen et al, 1990). Figure 6
(top panels) shows that after 48 h of organ culture Langerhans cells in
situ have acquired the expression of CD86; they are negative for 2A1
and they still express invariant chain. A similar expression pattern of
Langerhans cells in situ was observed 48 h after the application of a
contact sensitizer (3% TNCB; not shown): all Langerhans cells
remaining in the epidermis expressed invariant chain; many Langerhans
cells, though not all, became CD861. At the same time, most of the
strongly MHC class II-positive cells (i.e., DC) in the dermal ‘‘cords’’
of cultures are positive for both maturation markers, CD86 and 2A1
(Fig 6, bottom panels), used in this study. Many of them still contain
the invariant chain. Finally, the phenotype of DC that emigrated into
the culture medium over the culture period of 2–3 d corresponded to
that of mature DC, i.e. CD861/2A11. Yet, invariant chain was still
expressed in a variable but substantial percentage of DC (µ40% of all
MHC class II1 cells in three experiments: 20%/18%/82%). This was
reflected in the capacity of migrant DC to process a native protein
antigen much better than corresponding Langerhans cells cultured for
3 d (Fig 7). In contrast to cultured isolated Langerhans cells, Birbeck
granules could be easily identified in DC within lymph vessels (µ25%;
25 profiles of DC in three different experiments) and in DC that had
emigrated into the culture medium (µ10%; 50 profiles of DC in one
experiment).
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Figure 5. Ultrastructure of migratory DC within a lymph vessel (‘‘cord’’). Skin was cultured for 3 d and embedded for electron microscopy. In (A) many
cells displaying the ultrastructural features of DC can be seen inside a wide lumen of a vessel that is surrounded by a thin monolayer of endothelial cells (open
arrowheads). A nucleus of an endothelial cell protrudes into the lumen (closed arrowheads). DC possess irregular nuclei and extend many thin cytoplasmic processes
(‘‘veils’’). The star and asterisk mark the cells enlarged in (C) and (D), respectively. (B) Note the lack of a basement membrane on the ablumenal side of the
endothelial cell, anchoring filaments (thin arrows) and numerous pinocytotic vesicles (bold arrows). (C) High power of the cytoplasm of a DC. Smooth endoplasmic
reticulum and one runted Birbeck granule (arrow) become apparent. (D) Ultrastructure of another DC in the lumen of the lymph vessel. Note the tennis racket-
shaped Birbeck granule (arrow and enlarged in the upper inset). An organelle (from another DC) morphologically corresponding to an MIIC is shown in the lower
inset. Parts (E) and (F) show more prominent accumulations of typical anchoring filaments (thin, long arrows; short arrows point at longitudinally as well as transversely
sectioned collagen fibrils) on the ablumenal side of a lymph vessel. Lu, lumen; Co, collagen fibrils; N, nucleus. (A) scale bar, 3.5 µm; (B, C) lower inset in (D), scale
bar, 0.5 µm; (D) scale bar 5 1 µm; upper inset in (D), scale bar 5 0.2 µm; (E, F) scale bar 5 1 µm.
Table II. DC mature during migration. Expression of maturation markers and functional properties of migrating DC in skin
organ culturesa
MHC Invar. CD86 MoAb Prb Sc
class II chain 2A1
Freshly isolated Langerhans 11d 1 – 6 111 6
cells in vitro
Langerhans cells in situ in 1d,e 1 – – ntf nt
uncultured epidermis
Langerhans cells in situ in 111 1 1 – nt nt
epidermis from 2–3 d
cultured skin
Langerhans cells and dermal 111 1 11 111 nt nt
DC in situ in dermis from
3 d cultured skin/‘‘cords’’
Emigrated Langerhans cells 111d 11 11 111 11 111
and dermal DC in vitro
(‘‘crawl-out’’ cells)
Cultured Langerhans cells in vitro 111d – 11 111 6 111
aAntigen expression on epidermal and dermal sheets from skin cultured for 3 d was determined by immunohistochemistry. For comparison, staining patterns and functional data of
freshly isolated and 3 d cultured epidermal Langerhans cells are included. Fluorescence staining intensities are presented in an arbitrary scale (– to 111).
bPr, antigen processing capacity, as determined by means of peptide specific T cell hybridomas (Koch et al, 1995).
cS, sensitizing capacity for resting T cells, as determined in the allogeneic mixed leukocyte reaction (Schuler and Steinman, 1985; Lenz et al, 1993; Ortner et al, 1996).
dSurface expression.
eData from Kleijmeer et al (1994) and Mommaas et al (1995).
fnt, not testable.
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Figure 6. Migratory DC express matura-
tion markers as well as signs of immaturity
in situ. Epidermal (top two rows) and dermal
(bottom two rows) sheets from skin cultured for
48 h were double-immunolabeled for MHC
class II and the indicated molecules. Langerhans
cells in the epidermis and DC within ‘‘cords’’
express invariant chain (left column) and CD86
(middle column). Maturation marker 2A1,
however, is expressed only on DC within
‘‘cords’’ (right column, bottom pictures) but not on
Langerhans cells in the epidermis (right column,
top pictures). Scale bar, 25 µm.
Figure 7. Populations of DC that have emigrated into the culture
medium retain the capacity to process native protein antigen. Antigen
processing capacity of BALB/C DC that had emigrated into the culture medium
during the culture period of 3 d was measured by the response of a hen egg
lysozyme specific T cell hybridoma. Compared with a ‘‘classical’’ population of
mature DC, i.e., Langerhans cells that had been cultured for 3 d together with
keratinocytes (j), migratory DC (u) retain a considerable capacity to process
the protein and present it to the hybridoma (left panel). When tested for their
T cell sensitizing capacities in an allogeneic mixed leukocyte reactions, migrant
DC behave like typical mature DC (right panel). This experiment is representative
of three experiments.
DISCUSSION
Pathway of migration By immunohistochemistry and electron
microscopy we found a reduction of epidermal Langerhans cells and
typical string-like accumulations of DC in the dermis (‘‘cords’’) in
response to hapten stimuli as well as upon skin organ culture. These
data complement existing experimental evidence for the migration of
Langerhans cells to the lymphoid organs, and allow important conclu-
sions to be drawn. (i) Our data prove that migratory cutaneous DC
accumulate in and migrate through dermal lymphatic vessels. Blood
vessels are not a preferred pathway in the skin. This is analogous to
our previous findings in human skin organ cultures (Lukas et al, 1996).
The dermal pathway of DC migration as originally defined by the
work of Larsen et al (1990) leads indeed through the afferent lymphatics.
(ii) Our data provide additional evidence that a substantial number of
epidermal Langerhans cells physically leave the epidermis during organ
culture or the induction phase of contact hypersensitivity. They render
it unlikely that the decrease of immunohistochemically detectable
Langerhans cells in response to hapten treatment is merely due to a
loss of immunoreactivity of surface molecules. We base this conclusion
on the facts that (i) immunostaining for the cytoskeletal protein
vimentin revealed similar reductions in Langerhans cell densities as
immunostaining for cell surface molecules, and (ii) six different surface
molecules (MHC class II, F4/80, CD11b, CD32, DEC-205, ADPase)
decreased concomitantly. Thus, these findings broaden the experimental
basis for the concept that hapten-laden DC that have been recovered
from lymph nodes draining the sites of epicutaneous hapten application
are derived from cutaneous DC (Macatonia et al, 1987). Still, diffusion
of free or protein-bound hapten into the nodes cannot be ruled out.
This may be biologically relevant in a situation (low doses of hapten/
low zone tolerance) where hapten carriage by Langerhans cells does
not appear to play a role (Steinbrink et al, 1996).
Induction of migration In the contact hypersensitivity model the
emigration of Langerhans cells from the epidermis as well as the
formation of ‘‘cords’’ occurred specifically in response to contact
sensitizing agents but not to nonsensitizing (Botham et al, 1987)
compounds. The specificity in migratory behavior is paralleled by
sensitizer specific changes in the ultrastructural reaction patterns of
Langerhans cells (Kolde and Knop, 1987; Becker et al, 1994; Steinbrink
et al, 1996). There is also evidence that epicutaneously applied haptens
induce specific cytokine production patterns in epidermal cells. Most
notably, IL-α and MIP-2 in keratinocytes (Enk and Katz, 1992), and
IL-1β are upregulated in Langerhans cells (Enk and Katz, 1992). TNF-
α is induced nonspecifically in keratinocytes (Enk and Katz, 1992).
These cytokines were shown to be involved in migration of DC in
contact hypersensitivity (Enk et al, 1993; Cumberbatch et al, 1994) and
in skin organ cultures (unpublished observations). Their expression in
skin organ cultures has not yet been studied in detail. Messenger RNA
for granulocyte-macrophage colony stimulating factor has shown to
be elevated in murine skin organ cultures (Larsen et al, 1994).
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Derivation of migrating DC in the dermis The observation of
Birbeck granules in about one-fourth of ‘‘cord’’ DC strongly indicates
that part of these DC are epidermis derived. We had previously
observed the same in human skin organ cultures (Lukas et al, 1996).
Dermal DC (Lenz et al, 1993; Nestle et al, 1993; Duraiswamy et al,
1994) probably also migrate to the nodes via the same route because
‘‘cords’’ were also found in cultures of epidermis depleted dermis. The
functional competence of dermal DC for the induction of contact
hypersensitivity has been demonstrated (Streilein, 1989; Tse and
Cooper, 1990). We conclude that in whole skin cultures the DC
population in the dermal lymphatics is composed of both Langerhans
cells and dermal DC.
Maturation during migration We found that migratory DC display
the morphology and several phenotypical features of mature DC,
already within the epidermal environment. This confirms the work of
others who had noted that emigrating murine DC in the ‘‘cords’’
abundantly express costimulatory molecules recognized by the CTLA-
4 molecule (CD80 and/or CD86; Larsen et al, 1994); as do DC that
can be recovered from the culture medium and that have arrived there
from the epidermis and/or dermis, presumably via passage through
‘‘cords’’ (Inaba et al, 1994; Larsen et al, 1994; Pope et al, 1995). In
addition, our data suggest a sequence of phenotypical events in the
maturation of DC within the cutaneous environment (Table II). The
first signs of maturation are the upregulation of MHC class II (Larsen
et al, 1990) and the de novo expression of CD86 (still in the epidermis).
This is followed by the appearance of perinuclear 2A1 staining (in the
‘‘cords’’), and finally the loss of invariant chain. Pierre et al (1997) have
studied these changes in the same skin organ culture model at a more
refined level by using confocal microscopy. They additionally observed
a translocation of MHC class II molecules from intracellular endosomal/
lysosomal compartments in immature (‘‘early’’) DC to the plasma
membrane in mature (‘‘late’’) DC. These data underscore the notion
that migration and maturation of DC are tightly linked processes that
are triggered by the same stimuli.
Aiba and Katz (1990) have demonstrated that Langerhans cells
isolated from the epidermis 1 d after the application of contact sensitizers
express signs of functional maturity, i.e., an increased capacity to
stimulate resting T cells in an allogeneic mixed leukocyte reaction;
they still retain a considerable activity to process native protein antigens,
though. It seems that these cells have not yet completely developed
into fully mature DC. Populations of DC-containing cells at different
stages of maturation are not unusual. We have previously observed it
in Langerhans cells from standard 3 d epidermal cell cultures (Koch
et al, 1995). Three additional observations indicate that some features
of maturation might lag behind: (i) 1–2 d after the application of contact
allergens the remaining resident Langerhans cells had upregulated MHC
class II and, in part, CD86, but still expressed CD32, F4/80 macrophage
antigen, ADPase, and—most notably—invariant chain. Similarly, in
cultured skin, populations of maturing migratory DC within lymph
vessels (high MHC class II, CD861, in part 2A11) still displayed
invariant chain. In contrast, in Langerhans cells cultured for 2–3 d
these molecules can only be detected in minor subpopulations (invariant
chain; Koch et al, 1995) or not at all (CD32, F4/80, ADPase; Schuler
and Steinman, 1985) by immunohistochemistry. (ii) We readily found
Birbeck granules in DC located in the lymphatic vessels and, to a lesser
degree, in DC that had migrated into the culture medium. In cultured
epidermal Langerhans cells, however, this was virtually impossible
(Schuler and Steinman, 1985). (iii) The expression of invariant chain
in a substantial percentage of emigrated Langerhans cells/DC may
explain why these cell populations displayed a relatively high capacity
to process native protein antigens as compared with the standard
population of mature DC, namely cultured Langerhans cells (Koch
et al, 1995). It may also help explain the finding of substantial antigen
processing activity in populations of migratory rat lymph-derived DC
(Liu and MacPherson, 1995).
Comparison of contact hypersensitivity versus skin organ culture
model We were able to show similarities between the two models
in terms of kinetics and pathways of DC migration. The triggering of
migration and maturation by inflammatory cytokines also appears to
be similar in the contact hypersensitivity model (Enk and Katz, 1992;
Cumberbatch and Kimber, 1995) and in the skin organ culture model
(manuscript in preparation). This would emphasize the relevance and
importance of the latter model (Steinman et al, 1995) for studying
aspects of contact hypersensitivity. A major difference is the extent to
which dermal ‘‘cords’’ are formed: many ‘‘cords’’ are formed in skin
organ cultures but few are formed in the in vivo contact hypersensitivity
model (Silberberg-Sinakin et al, 1976; Schuler et al, 1991). A reason
for this might be that in the organ cultures the lymphatic vessels
are artificially (partly) clogged, which would result in the observed
accumulation of DC. In vivo, however, the lymph flow is not obstructed
and therefore ‘‘cords’’ do not become obvious that frequently. We
believe that skin organ culture will prove useful for investigating the
interplay of cytokines and adhesion molecules involved in migration.
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